These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31853741)

  • 1. Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients.
    Cazavet J; Bounes FV; Ruiz S; Seguin T; Crognier L; Rouget A; Fourcade O; Minville V; Conil JM; Georges B
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):527-538. PubMed ID: 31853741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study.
    Kim HS; Lee E; Cho YJ; Lee YJ; Rhie SJ
    J Clin Pharm Ther; 2019 Feb; 44(1):84-90. PubMed ID: 30243033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
    Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.
    Dong HY; Xie J; Chen LH; Wang TT; Zhao YR; Dong YL
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1029-35. PubMed ID: 24515096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
    Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
    J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid.
    Zhang YM; Yu W; Zhou N; Li JZ; Xu LC; Xie ZY; Lu YF; Li LJ
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):287-92. PubMed ID: 26063030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery.
    Ikuta S; Tanimura K; Yasui C; Aihara T; Yoshie H; Iida H; Beppu N; Kurimoto A; Yanagi H; Mitsunobu M; Yamanaka N
    J Infect Chemother; 2011 Jun; 17(3):388-91. PubMed ID: 21161560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.
    Dou L; Meng D; Dong Y; Chen L; Han X; Fan D; Dong H
    Int J Infect Dis; 2020 Jul; 96():105-111. PubMed ID: 32251797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination.
    Kaya Kılıç E; Bulut C; Sönmezer MÇ; Ozel Ö; Ataman Hatipoğlu Ç; Tuncer Ertem G; Tülek N; Kınıklı S
    J Infect Dev Ctries; 2019 Oct; 13(10):886-891. PubMed ID: 32084018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia.
    Onita T; Ishihara N; Ikebuchi A; Yano T; Nishimura N; Tamaki H; Ikawa K; Morikawa N; Naora K
    J Clin Pharm Ther; 2022 Dec; 47(12):2041-2048. PubMed ID: 35893441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.
    Tsuji Y; Holford NHG; Kasai H; Ogami C; Heo YA; Higashi Y; Mizoguchi A; To H; Yamamoto Y
    Br J Clin Pharmacol; 2017 Aug; 83(8):1758-1772. PubMed ID: 28186644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of clinical factors with thrombocytopenia in patients receiving linezolid treatment: a retrospective study.
    Thi Phuong Thao L; Duc Trung N; Thi My L; Minh Hong L; Viet Hoan B; Quang Hung V; Dang Hai P
    J Infect Dev Ctries; 2024 Feb; 18(2):285-290. PubMed ID: 38484357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for linezolid-induced thrombocytopenia in adult inpatients.
    Han X; Wang J; Zan X; Peng L; Nie X
    Int J Clin Pharm; 2022 Apr; 44(2):330-338. PubMed ID: 34731363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases.
    Choi GW; Lee JY; Chang MJ; Kim YK; Cho Y; Yu YM; Lee E
    Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):228-234. PubMed ID: 30171804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and validation of a risk prediction model incorporating concentrations of linezolid and its metabolite PNU142300 for linezolid-induced thrombocytopenia.
    Xu J; Lu J; Yuan Y; Duan L; Shi L; Chen F; Cao Y; Xu G; Feng Z; Li L; Xue H; Sun J; Zhou Q; Zhuang Z; Tang L
    J Antimicrob Chemother; 2023 Aug; 78(8):1974-1981. PubMed ID: 37341139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia.
    Hanai Y; Matsuo K; Ogawa M; Higashi A; Kimura I; Hirayama S; Kosugi T; Nishizawa K; Yoshio T
    J Infect Chemother; 2016 Aug; 22(8):536-42. PubMed ID: 27321773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of linezolid on platelet count in critically ill patients with thrombocytopenia.
    Tatsumi H; Akatsuka M; Kuroda H; Kazuma S; Suzuki S; Masuda Y
    PLoS One; 2023; 18(6):e0286088. PubMed ID: 37384758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients.
    Wicha SG; Mair A; Chiriac U; Frey OR; Fuchs T; Gaasch M; Hagel S; Richter DC; Roberts JA; Röhr AC; Weigand MA; Brinkmann A
    Int J Antimicrob Agents; 2022 May; 59(5):106572. PubMed ID: 35307562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid-Associated Thrombocytopenia in Children With Renal Impairment.
    Jones SJ; Nichols KR; DeYoung HL; Cox EG; Knoderer CA
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):272-5. PubMed ID: 26407433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.